GFN Voices with Michael Kariuki #GFN23

Join us for the seventeenth episode of GFN Voices 2023!

GFN Voices with Giorgi Mzhavanadze #GFN23

Three leading tobacco harm reduction experts join us to give their predictions, hopes and fears for the Tenth Conference of the Parties of the FCTC, which was due to take place on 20 November 2023 before being postponed at the eleventh hour.

GFN News #76 | COP10 PREDICTIONS | Leading THR experts discuss their hopes and fears

GFN 2024 Keynote #1 - delivered by Andrzej Fal, hosted by Grzegorz Król, response from Michelle Minton - titled "Health and economic benefits of tobacco harm reduction".

- What does the current evidence tell us about the potential health and economic benefits of safer nicotine products?
- How should we weight this evidence?
- What more do we need to know, what is the prognosis for the future and what are the short and long-term costs of different policy alternatives?
- How might legislators and regulators balance health and economic imperatives to achieve positive outcomes?
- What factors might make for an effective legislative and regulatory framework?
- How should future progress be monitored, and policies adjusted in response?

Health and economic benefits of tobacco harm reduction - Keynote #1 | #GFN24

GFN 2024 Keynote #2 - delivered by Garrett McGovern, response from Alex Wodak - titled "Over/misinterpretation of the precautionary principle in relation to safer nicotine".

Whilst no activity has a total absence of risk, science has to embrace risks and challenges to evolve. The over/misinterpretation of the precautionary principle is often an impediment to progress. Drawing on his experience of working with dependence in other fields, Dr McGovern will examine, in relation to nicotine use:

- How should we categorise/quantify risk?
- Is there a hierarchy of risk(s)?
- What are the consequences of avoiding all risks?
- How can equivalence assist in assessing risk?
- Who should determine the limits of risk – for the individual and communities?
- Are there lost opportunities for tobacco harm reduction to have a significant impact on personal and societal health improvement, due to the inappropriate application of the precautionary principle?

Misinterpretation of the precautionary principle in relation to safer nicotine - Keynote #2 | #GFN24

GFN 2024 Keynote #3 given by Vivien Azer, hosted by David Sweanor, response from Jonathan Fell

Vivien is a nicotine market specialist, and until recently, the Managing Director & Senior Analyst, Global Beverages, Tobacco and Cannabis, at TD Cowen, in New York City.
In her keynote she will address a number of themes, among them:

- What factors prompted and drove initial investment in this field?
- What is the state of the current market?
- Who are the major investors/stakeholders?
- What might be the impact of regulation – and possible prohibition – on future investment and the - development of the next generation of safer nicotine products?
- Are there lessons to be learnt from other emerging markets, for example the market for medicinal and recreational cannabis?

Tobacco harm reduction market influence - past, present and future - Keynote #3 | #GFN24

Michael Russell Award 2024 - presented to Dr. Colin Mendelsohn by Professor Gerry Stimson

Michael Russell Award 2024 | #GFN24

Australia intensified its war on vaping with new, punitive regulations that will criminalize nicotine vaping products to an extent unseen in the Western world. The government explicitly states that its goal is to 'reverse the increasing uptake of recreational nicotine.

Featuring:
Prof., Dr. Sharifa Ezat Wan Puteh
Physician, Prof. Public Health, National University of Malaysia
Chairman of the Malaysia Society of Harm Reduction

GFN.TV Interviews | HIGH BURDEN | Illicit Combustible Tobacco & Vapes Take Toll on Malaysia

How health, economics and harm reduction interact? | GFN Voices 2024 #1

An examination of the health and economic impact of tobacco control measures and the role for proportionate regulation and risk management for alternative nicotine products.

GFN 2024 Panel Discussion #2 - hosted by Clive Bates with panellists: David Sweanor, Nevena Crljenko, Konstantinos Farsalinos and Joe Thompson.

Legislation and regulation - health and economic consequences - Panel Discussion #2 | #GFN24

An examination of the health, social and economic costs of prohibition, with a panel reflecting on parallel experiences with illicit drugs and alcohol. The panel comprises politicians, thought leaders from the drug and alcohol fields and a consumer/vape trader perspective.

GFN 2024 Panel Discussion #1 - hosted by Ethan Nadelmann with panellists: Fiona Patten, Lindsey Stroud, Sharifa Ezat Wan Puteh, Harry Shapiro.

The costs of prohibition - Panel Discussion #1 | #GFN24

Philip Morris International is at the centre of the battle over the coming smoke-free world, having spent billions transitioning to reduced-risk products like oral tobacco, heated tobacco products, and vaping. Yet they are still one of the largest producers of combustible tobacco products. How is the journey to the smoke free future going?  

Featuring:
Ondrej Koumal
Director External Affairs, Philip Morris International
pmiscience.com

GFN.TV Interviews | DEMAND DELUSION | PMI On the Battle for A Smoke-Free Future

The hosts, together with a panel representing scientists, consumers and other stakeholders will review a selection of scientific papers, published in the past 12 months, on nicotine and THR-related issues, identifying the best and worst examples.

GFN 2024 Panel Discussion #3 - hosted by Clive Bates with panellists: Arielle Selya, Gizelle Baker and Roberto Sussman.

Rating the evidence - good and bad science - Panel Discussion #3 | #GFN24

Harry Shapiro is joined by Lindsey Stroud and David Sweanor for this Commentary Team session, filmed at the 2024 edition of the Global Forum on Nicotine!

Join us for an in-depth look at these crucial topics with insights from leading experts at the Global Forum on Nicotine 2024! Overview of progress and challenges in tobacco harm reduction across different regions, examination of diverse regulatory landscapes and the impact of political decisions on harm reduction, analysis of the financial aspects of harm reduction policies, including healthcare cost savings and market dynamics.

REASONS TO BE CHEERFUL | GFN24 Commentary Team hosted by Harry Shapiro

Join us for an in-depth live commentary from the Global Forum on Nicotine 2024, held in Warsaw! In this video, Will Godfrey of Filtermag sits down with two of the leading advocates in the field of tobacco harm reduction: Fiona Patten and Samrat Chowdhery.

Fiona Patten's take on the prohibition impact in Australia and the rise of illegal markets.
Samrat Chowdhery's insights into the black market consequences and the future of regulation in India.
For anyone interested in tobacco harm reduction, public health policies, or the global challenges and advancements in nicotine regulation, this discussion offers valuable perspectives from two passionate advocates.

RACE TO THE BOTTOM? | GFN24 Commentary Team hosted by Will Godfrey

Join Brent Stafford of RegWatch as he hosts an engaging panel with renowned harm reduction advocates from Australia, the UK, and Canada. In this lively discussion, our experts tackle critical issues facing Commonwealth countries.

Featuring Fiona Patten, Martin Cullip, and Maria Papaioannoy, this conversation dives deep into the contradictions and complexities of harm reduction strategies in the Commonwealth. Don't miss their insightful perspectives and thought-provoking debate on the future of tobacco control and vaping regulations. Tune in now for this must-watch discussion!

WHAT’S WRONG WITH THE COMMONWEALTH? | GFN24 Commentary Team hosted by Brent Stafford

Join host Rebecca Taylor, a health policy specialist and former member of the European Parliament, as she leads an insightful discussion on the recent European election results and their implications for tobacco harm reduction, featuring:
 - Michael Landl - Director of the World Vapers Alliance from Austria;
- Konstantinos Farsalinos - Physician and public health researcher from Greece;
- Fernando Fernandez Bueno - Oncology surgeon and tobacco harm reduction advocate from Spain.

Are the EU election results promising for THR? | GFN24 Commentary Team hosted by Rebecca Taylor

We all have to have a voice in this discussion! | GFN24 Commentary Team hosted by Sarah Cooney

Despite considerable scientific evidence to support the efficacy - and relative safety - of safer nicotine products (SNPs) powerful voices continue to place obstacles in the way of consumers. Consumers are an often neglected voice in the debates that often result in disproportionate regulation, restrictions on sales and use and outright bans applied to SNPs. There are some notable exceptions, where consumers have had their voices heard and garnered support from legislators, resulting in a more balance and nuanced approach.

This session will attempt to ’take stock’ of where we are and what the next steps might look like, and will be consumer lead, with panellists from different regions reflecting on how the debate has been conducted and what influence they may have been able to bring to bear. What are the challenges and what strategies can have a positive impact? How can the science supporting SNPs be effectively promoted and how can the consumer experience be incorporated - ’nothing about us without us’? Who are the key actors and how might they be engaged in a constructive way? What can most effectively assist consumer advocacy to succeed?

GFN 2024 Workshop - hosted by Tom Gleeson with panellists: Ignacio Leiva, Carissa Düring and Asa Saligupta.

Full programme of GFN 2024: https://gfn.events/events-timeline/global-forum-on-nicotine-2024/programme/

Consumer experience of the increasingly complex THR landscape - Workshop | #GFN24

An examination of the nature of the THR debate, including different factions' objectives and the tactics being used, such as misinformation, emotive appeals and personal attacks. Panellists will share their own experiences, discuss why the debate is being conducted as it is, and ask how we should best operate in a challenging and often hostile environment.

GFN 2024 Panel Discussion #4 - hosted by Will Godfrey with panellists: Marewa Glover, Rohan Sequeira, Maria Papaioannoy-Duic, Christopher Snowdon

The global culture war over THR - Panel Discussion #4 | #GFN24

Tragically, those who should know better—medical doctors, public health officials, and the media—are reluctant to promote nicotine vaping as a tool for harm reduction. Instead, they make a deliberate choice to ignore or avoid acknowledging the truth about vaping. This problem is widespread, including in Latin America. Learn more in this special hybrid English/Spanish episode of GFN Interviews.

Featuring:
DR. DIEGO VERRASTRO
Physician, General and Emergency Surgery
Co-founder, Latin American Network for THR, RELDAT.org

JEFFREY ZAMORA
President, Asovape Costa Rica & of ARDT Iberoamerica
Director of Social Media, INNCO
@jeffzam8

GFN.TV Interviews | WILLING IGNORANCE | Reluctance to Promote Nicotine Vapes for Harm Reduction

We delve into the key insights and discussions from the Global Forum on Nicotine (GFN). Our expert speakers share their experiences and reflections on the evolution of tobacco harm reduction, exploring the intersection of science, economics, and politics. Learn about the challenges faced, the progress made, and the future of tobacco harm reduction in public health.

Lessons from GFN on Tobacco Harm Reduction | GFN Voices 2024 #2

Regulation round up – global perspectives - Workshop | #GFN24

Supporting tobacco harm reduction is more than just pragmatic positioning to appease financial analysts and stakeholders. For Imperial Brands, one of the world’s major tobacco companies, THR represents a consumer-focused commitment to helping individuals switch to less harmful forms of tobacco. It's a strategy that balances both head and heart, reflecting a thoughtful approach to the future of safer nicotine products.

Featuring:
Joe Thompson
Group Science & Regulatory Affairs Director, Imperial Brands

GFN.TV Interviews | HEART PART | Imperial Brands Calls THR the ‘Right Thing to Do’

In this video, we dive into the highlights and key takeaways from a recent global advocacy conference. Hear from Michael Landl as he shares his favorite sessions, including an inspiring talk by Ethan Nadelmann. Learn about the importance of community, shared experiences, and effective strategies across different countries.
Featuring Michael Landl, Jarkyn Shadymanova and Pranay Ratna Sakya.

Full programme of GFN 2024: https://gfn.events/events-timeline/global-forum-on-nicotine-2024/programme/

What are the key insights from Global Forum on Nicotine? | GFN Voices 2024 #3

For Tobacco Harm Reduction (THR) to become widespread, affordable and appealing, reduced-risk alternatives to harmful tobacco products must be legally available and accessible. Achieving this requires sustained, substantial investment. The pace of harm reduction is closely tied to investment levels, influenced by potential risks and returns. Regulatory risk and uncertainty increase the returns required by investors, reducing available capital. Consequently:

- Reduced Investment in Product Development: Lower investment hinders the development of safer and more appealing products supported by scientific research. Without this, regulators are unlikely to consider them as effective harm-reduction solutions, and existing RRPs do not appeal to most smokers.
- Limited Accessibility in the Global South: Insufficient investment in cost reduction makes these products inaccessible to consumers in the Global South, home to 80% of harmful tobacco users.
- Hesitancy to Enter High-Risk Markets: Companies and investors are less likely to enter markets with high regulatory risk.

GFN 2024 Workshop - hosted by Pieter Vorster with panellists: Sud Patwardhan, Jonathan Fell and Marina Murphy

Regulatory risk, investment and tobacco harm reduction - Workshop | #GFN24

This workshop will explore the horizontal relationship of physicians, consumer advocates, and regulators to promote science-based communication and harm reduction alternatives to advance public health.

GFN 2024 Workshop - hosted by Jeffrey Zamora and Carmen Escrig with panellists: Jorge Palma, Diego Verrastro, Tomás O'Gorman, Fernando Bueno

Full programme of GFN 2024: https://gfn.events/events-timeline/global-forum-on-nicotine-2024/programme/

Harnessing the power of physicians, consumer advocates and regulators to promote THR | #GFN24

Spreading misinformation about nicotine vaping to vulnerable populations leads to dire consequences, warns Kiran Sidhu, a leading THR writer-journalist for Filter.

Featuring:
KIRAN SIDHU
Writer-Journalist, Filter
Tobacco Harm Reduction Fellow
filtermag.org
@KiranSidhu41

GFN.TV Interviews | Are Anti-THR Campaigners Guilty of Taking Lives?

In this insightful discussion, Liza Katsiashvili, Andrzej Fal and Ethan Nadelmann tackle the growing misconceptions surrounding vaping and tobacco harm reduction. Learn how misinformation, fueled by media and powerful institutions like the WHO, is shaping public opinion and preventing effective harm reduction strategies.

Unveiling the Truth About Nicotine | GFN Voices 2024 #4

In today's GFN Voices, Kurt Yeo explores the crucial relationship between economics, health, and tobacco harm reduction. With a focus on South Africa, he delves into the burden tobacco places on public health, the economic challenges it creates, and how harm reduction strategies could be the key to a healthier future.

A South African Perspective on Tobacco Harm Reduction | GFN Voices 2024 #5

Science is an enabler at Japan Tobacco International, driving innovation in risk-reduced tobacco products and reinforcing its position when responding to critics. 'Each scientific study is a piece of the puzzle,' says Ian Jones, V.P. of the Scientific Product Assessment Center at JTI.

Featuring:
IAN JONES
V.P., Scientific Product Assessment Center
Japan Tobacco International
jti.com

GFN.TV Interviews | JTI SCIENTIST ON SOLVING RISK-REDUCED PRODUCTS PUZZLE

Global Impact of Tobacco Harm Reduction | #GFNVoices24 #6

New legislation in Australia means that vapes can only be bought in pharmacies, with e-liquid only available in three flavours. What are the likely consequences of this, in a country where the black market for vaping products is already booming?

GFN News #114 | DOOMED TO FAIL | Colin Mendelsohn explains Australia's new vape regulations

The Global Forum on Nicotine (GFN) has taken place every year since 2014 and is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, this is the homepage of GFN•TV, the broadcast arm of the GFN stable.

GFN•TV regularly broadcasts GFN•TV news and interviews, given by Brent Stafford. We also livestream the annual GFN conference, live from Warsaw and release all the session videos and GFN•TV Commentary Team discussions post event.

Tune in to hear world-leading experts, tobacco harm reduction advocates and nicotine consumers discuss the latest scientific, regulatory and policy developments.

From our unique annual event, to year-round reporting of the issues that matter in tobacco harm reduction, GFN has got it covered.

Popular tracks by GFN•TV